These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 8120369)

  • 1. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
    Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
    J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gld/gld mice are unable to express a functional ligand for Fas.
    Ramsdell F; Seaman MS; Miller RE; Tough TW; Alderson MR; Lynch DH
    Eur J Immunol; 1994 Apr; 24(4):928-33. PubMed ID: 7512035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-restricted lymphoproliferation in autoimmune lpr mice.
    Matsuzawa A; Kimura M; Muraiso T; Kominami R; Katagiri T
    Eur J Immunol; 1991 Jun; 21(6):1535-42. PubMed ID: 2044659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
    Weston KM; Yeh ET; Sy MS
    J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation from mutant lpr/lpr mice. Functional abnormalities rather than alloantigenic differences appear to determine the development of a graft-vs.-host-like syndrome.
    Allen RD; Marshall JD; Roths JB; Sidman CL
    Eur J Immunol; 1990 Sep; 20(9):2057-66. PubMed ID: 2209703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice.
    Gillette-Ferguson I; Sidman CL
    Eur J Immunol; 1994 May; 24(5):1181-5. PubMed ID: 8181528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease.
    Perkins DL; Michaelson J; Glaser RM; Marshak-Rothstein A
    J Immunol; 1987 Sep; 139(5):1406-13. PubMed ID: 2887617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand.
    Sobel ES; Kakkanaiah VN; Kakkanaiah M; Cohen PL; Eisenberg RA
    J Immunol; 1995 Jan; 154(1):459-64. PubMed ID: 7527822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice.
    Reap EA; Leslie D; Abrahams M; Eisenberg RA; Cohen PL
    J Immunol; 1995 Jan; 154(2):936-43. PubMed ID: 7529292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages.
    Glaser RM; Marshak-Rothstein A
    Eur J Immunol; 1990 Sep; 20(9):1917-25. PubMed ID: 2209698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T; Davidson WF
    J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular interactions in the lpr and gld models of systemic autoimmunity.
    Sobel ES
    Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of murine T cells via the Ly-6C antigen: lack of proliferative response in aberrant T cells from lpr/lpr and gld/gld mice despite high Ly-6C antigen expression.
    Dumont FJ
    J Immunol; 1987 Jun; 138(12):4106-13. PubMed ID: 2438334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective T cells from gld mice play a pivotal role in development of Thy-1.2+B220+ cells and autoimmunity.
    Yasutomo K; Maeda K; Nagata S; Nagasawa H; Okada K; Good RA; Kuroda Y; Himeno K
    J Immunol; 1994 Dec; 153(12):5855-64. PubMed ID: 7527451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haematopoietic cell transfers between C57BL/6 mice differing at the lpr or gld locus.
    Montecino-Rodriguez EM; Loor F
    Immunology; 1991 Sep; 74(1):127-31. PubMed ID: 1682243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes.
    Sobel ES; Yokoyama WM; Shevach EM; Eisenberg RA; Cohen PL
    J Immunol; 1993 Jan; 150(2):673-82. PubMed ID: 8380429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice.
    Davidson WF; Dumont FJ; Bedigian HG; Fowlkes BJ; Morse HC
    J Immunol; 1986 Jun; 136(11):4075-84. PubMed ID: 3009614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.